. Other than 1 Filipino 2 year old girl (patient C), all other infants were of Chinese Singaporean origin and were less than age 1 year at onset; 4 male and 1 female. All patients were found to have multiple areas of irregular, thickened vessel walls with enhancement, involving the aorta and additional medium sized arteries on Magnetic Resonance Angiography (MRA). Only patients C and F presented with prolonged fever and or less than 1 clinical feature of KD. C developed a unilateral enlarged lymph node on recrudescence of fever 1 month after the initial event. She was then found to have dilated CA (dCA) and consequently abnormal MRA. Other patients had significant KD Index scores and complete KD presentations. Of the 4 patients who received only 1 dose of IVIG; C and F had diagnosis change from atypical KD to Takayasu Arteritis and G developed rhinovirus and then rotavirus as reason for prolonged fever. Patient A received IV steroids and then Infliximab. All patients received steroids. Patients A and B both developed a psoriasiform rash post-Infliximab which resolved on follow up. Patient F and Patient B died 3 months and 17 months after diagnosis. Patient F, presented with fever, fussiness and enteritis aged 4 months. Her symptoms recurred 2 weeks after onset. Due to differential hypertension, she received an echocardiogram and subsequently MRA and cardiac catherization. Cause of death at age 7 months was small bowel perforation with arteritis and consequent intra-abdominal sepsis. Patient B, presented with complete features of KD at age 2 months. His course was noted for recrudescence 2 weeks and 4 weeks after initial IVIG. He developed giant coronary aneurysms with abnormal MRA findings; developed myocardial infarction at age 8 months and proceeded to require a Left Ventricular Assist Device but died age 13 months from multi-organ failure. 3/6 (50%) developed aneurysms, D and F were giant. 4 surviving patients, had improvement in all vessels but continued activity in the aorta on follow up MRA, they remain on Methotrexate with no active clinical findings.
Conclusions:
Extensive involvement of the systemic arteries and aorta in all patient were noted on initial MRA. Follow up imaging, showed improvement in all vessels. After 1 year of follow up, complete resolution occurred only in medium vessels. Mortality in this patient cohort was 2/7 (28.6%). This is an observational case series and our findings will need to be reproduced in larger groups of patients. Background: Juvenile idiopathic arthritis (JIA) is a chronic arthritis with an onset before 16 years of age, that persists for at least 6 weeks, and has an unknown etiology.
1 Uveitis is a serious and common extra-articular manifestation of JIA, affecting 12-30% of patients (most commonly female with ANA+ oligoarthritis JIA category).
2,3 JIA-associated uveitis can be treated with biologic disease modifying antirheumatic drugs (bDMARDs), including TNF inhibitors (TNFi) such as etanercept (ETN), infliximab (IFX), and adalimumab (ADA), after failure of first-line treatments, such as topical corticosteroids and/or conventional synthetic DMARDs (csDMARDs), such as methotrexate (MTX).
2 Of note, reports exist that ETN use has been associated with uveitis flares or new-onset uveitis while an observational study reported similar uveitis flare rates for both ADA and ETN.
4,5
Objectives: To conduct an analysis on the occurrence of uveitis in patients with JIA treated with ETN, ADA, or MTX. Combination therapy of ETN, ADA, and MTX was also assessed. Methods: International Statistical Classification of Diseases (ICD)-9 diagnosis codes in a Truven MarketScan ® claims database were used to identify JIA patients diagnosed with uveitis over a 5-year interval. The analysis assessed the proportion of JIA patients (aged 0-19 years) treated with ETN, ADA, or MTX, as monotherapy or in combination. The percentage of patients diagnosed with uveitis and the time interval for uveitis diagnosis in patients with JIA was determined. Results: A total of 22,789 patients with JIA where included in this analysis and exhibited a mean age of 11.4 years, were predominantly female (69%), and mean JIA disease duration was 3 years. This total included 19,814 patients with chronic, or not otherwise specified, polyarticular JIA. A total of 2581 (11.3%) patients, of mean age 10.2 years, of which 73% were female, were diagnosed with uveitis. The numbers of JIA patients receiving biologic and/or MTX therapy and proportions with a uveitis diagnoses are shown in the Figure. Conclusions: This analysis showed a similar occurrence of uveitis in JIA patients treated with ETN or ADA, either as monotherapy or in combination with MTX. Background: Delayed puberty is common in children with chronic illnesses such as Juvenile Idiopathic Arthritis (JIA),especially in cases with an earlier age of onset.Its etiology is multifactorial and includes low weight,complications arising from the disease itself and the adverse effects of treatment. Objectives: To compare uterine and ovarian size as well as artery pulsatility between girls with juvenile idiopathic arthritis (JIA) and healthy participants using abdominal pelvic ultrasound,and identify these findings and pubertal staging,sex hormones and disease characteristics in girls with JIA. Methods: This study involved 44 girls with JIA and 59 healthy controls aged between six and 18 incomplete years.Pelvic ultrasound was used to determine uterine volume and length,the corpus/cervix ratio,ovarian volume and length,and the pulsatility index (PI) of uterine arteries.Hormone levels were also measured in girls with JIA. Results: All US parameters were associated with Tanner stages in the control group (p<0.001).Uterine and ovarian measures were smaller in girls with JIA 2.9 (1.5-6.3) 5.9 (3.0-9.1) 0.006 Mean uterine PI 4.6 (2.7-6.5) 2.5 (1.9-5.1) 0.025 PI, pulsatility index. *Described as median (25th-75th percentile) or mean ± standard deviation.
than in the control group.The mean PI of uterine arteries was higher in girls with JIA.Comparisons by age group revealed that uterine volumes were smaller in girls with JIA aged between 10 and 11 years (p=0.004) and 14 to 15 years (p=0.042),and the corpus/cervix ratio was smaller in girls aged 10 to 11 years (p=0.007).US measures were not associated with disease factors in the JIA group.LH and estradiol levels were found to be positively associated with ovarian and uterine size (p<0.001),but negatively correlated with the mean PI of uterine arteries (p<0.01). Conclusions: Pelvic US is a sensitive method for the assessment of sexual maturation in girls,and can identify developmental delays in girls with JIA which may not be detected by Tanner Objectives: To analyze Th1 and Th17 cell subsets in patients with ERA and to compare with age-matched healthy controls. To assess the association between disease activity and disease clinical pattern with Th1and Th17 cells subsets Methods: Patients with ERA (according to ILAR criteria) were included in a cross sectional study. Disease activity measures were collected in random visits: active joint count (AJ), pain score (0-10), presence of active enthesitis (AE), sacroiliac pain (SIP), lumbar pain (LP),lumbar limitation (LL) by Schöber's test, wellbeing according to the patient using a visual analogue scale (VASp, 0-10), disease activity according to the physician (VASphy, 0-10), JADAS-10, JSpADA, and ESR/CRP were evaluated. Patients were classified based on the disease pattern (peripheral and non-peripheral) depending on the presence or absence of AJ and/or AE. Functional capacity was also assessed by CHAQ. Presence of radiologic sacroiliitis (MRI/X-rays) and treatment with TNF inhibitors (TNFi) were recorded. Th-17 and Th-1 cells were quantified by flow cytometry in PBMCs stimulated with PMA/IO. Age-matched healthy children without disease or medication were recruited as normal control. Comparison between groups (Mann-Whitney Utest) and correlation tests as appropiate Results: Twenty-nine patients (90% M) fulfilled inclusion criteria. HLA-B27 was positive in 13 (45%). Median age at observation was 12 years and median disease duration was 2.1 years. Activity and functional measures were (medians): AJ 1, pain 0.25, VASp 0.5, VASphy 1, JADAS-10 7, JSpADA 1.75, ESR 15 mm/h, and CHAQ ≥0,5=8 patients (27%). AE was present in 1 (3%), SIP in 7 (24%), LP in 6 (21%), and LL in 12 (41%) children. Nineteen (65%) patients showed JADAS >1 and 21 (76%) JSpADA>0. Radiologic sacroilitis was recorded in 21 (72%) children. Fourteen (48%) patients were treated with TNFi. Th1cell percentage in ERA was 8.5±3.4% (range, 4-17.4) while healthy controls was 5.8±3.8% (range, 1.2-14.2), p=0.023. Th17cell% in ERA was 0.90±0.44 (range, 0.39-2.34%) while controls was 0,55±0.38 (range, 0,17-1,61%); p=0.004. There was no difference between T-cells% and active/inactive disease. Eighteen (62%) children showed peripheral pattern, while 11 (38%) exhibited non-peripheral. Peripheral and non-peripheral groups showed Th17%cells 0.90 (0.39-1.74) vs 1.14 (0.64-2.44) respectively (p=0.018).Significant correlations were Th1 with AJ (r=0.45 p=0.004) and Th17with LP (r=0.83 p=0,0001), LL (r=0.47 p=0.03). Conclusions: Th1 and Th17 cells subsets were significantly higher in ERA compared with healthy controls. However, T-cells showed no significant difference between patients with active versus inactive disease. Interestingly, non-peripheral pattern showed higher Th17% cells respect to patients with peripheral disease.Our results suggest that Th17 evaluation could help identify different phenotypes that benefit from Th-17 blocking strategies. Background: MRP8/14 (also known as calprotectin) has been widely studied as
